Personal tools

MCL coexpression mm9:3224: Difference between revisions

From FANTOM5_SSTAR

Jump to: navigation, search
No edit summary
No edit summary
Line 6: Line 6:
|ontology_enrichment_disease=
|ontology_enrichment_disease=
|ontology_enrichment_uberon=UBERON:0004121!2.47e-24!95;UBERON:0000924!2.47e-24!95;UBERON:0006601!2.47e-24!95;UBERON:0001016!1.18e-22!75;UBERON:0001017!8.75e-20!73;UBERON:0002346!5.72e-16!64;UBERON:0003075!5.72e-16!64;UBERON:0007284!5.72e-16!64;UBERON:0000073!6.95e-15!54;UBERON:0010371!2.65e-13!73;UBERON:0001049!3.98e-12!52;UBERON:0005068!3.98e-12!52;UBERON:0006241!3.98e-12!52;UBERON:0007135!3.98e-12!52;UBERON:0003056!8.78e-12!49;UBERON:0002420!7.26e-11!8;UBERON:0007245!7.26e-11!8;UBERON:0010009!7.26e-11!8;UBERON:0010011!7.26e-11!8;UBERON:0000454!7.26e-11!8;UBERON:0002950!4.70e-10!4;UBERON:0001891!4.70e-10!4;UBERON:0009616!4.70e-10!4;UBERON:0010286!4.70e-10!4;UBERON:0010314!2.09e-09!92;UBERON:0002616!1.89e-08!46;UBERON:0002038!2.08e-08!3;UBERON:0009663!2.08e-08!3;UBERON:0009661!2.08e-08!3;UBERON:0000125!2.08e-08!3;UBERON:0002308!2.08e-08!3;UBERON:0000955!3.36e-08!47;UBERON:0006238!3.36e-08!47;UBERON:0002020!1.08e-07!34;UBERON:0003080!2.04e-07!40;UBERON:0001948!2.34e-07!5;UBERON:0002315!2.34e-07!5;UBERON:0000011!2.87e-07!3
|ontology_enrichment_uberon=UBERON:0004121!2.47e-24!95;UBERON:0000924!2.47e-24!95;UBERON:0006601!2.47e-24!95;UBERON:0001016!1.18e-22!75;UBERON:0001017!8.75e-20!73;UBERON:0002346!5.72e-16!64;UBERON:0003075!5.72e-16!64;UBERON:0007284!5.72e-16!64;UBERON:0000073!6.95e-15!54;UBERON:0010371!2.65e-13!73;UBERON:0001049!3.98e-12!52;UBERON:0005068!3.98e-12!52;UBERON:0006241!3.98e-12!52;UBERON:0007135!3.98e-12!52;UBERON:0003056!8.78e-12!49;UBERON:0002420!7.26e-11!8;UBERON:0007245!7.26e-11!8;UBERON:0010009!7.26e-11!8;UBERON:0010011!7.26e-11!8;UBERON:0000454!7.26e-11!8;UBERON:0002950!4.70e-10!4;UBERON:0001891!4.70e-10!4;UBERON:0009616!4.70e-10!4;UBERON:0010286!4.70e-10!4;UBERON:0010314!2.09e-09!92;UBERON:0002616!1.89e-08!46;UBERON:0002038!2.08e-08!3;UBERON:0009663!2.08e-08!3;UBERON:0009661!2.08e-08!3;UBERON:0000125!2.08e-08!3;UBERON:0002308!2.08e-08!3;UBERON:0000955!3.36e-08!47;UBERON:0006238!3.36e-08!47;UBERON:0002020!1.08e-07!34;UBERON:0003080!2.04e-07!40;UBERON:0001948!2.34e-07!5;UBERON:0002315!2.34e-07!5;UBERON:0000011!2.87e-07!3
|tfbs_overrepresentation_for_novel_motifs=0.752782,0.193418,0.722405,0.801166,0.587814,0.81763,0.919454,0.467321,0.479531,0.235304,0.870507,0.906098,0.467629,0.933025,0.608226,0,1.14208,1.41496,0.448066,0.328717,0.679146,0.756749,0.932027,0.585919,0.731217,0.963352,0.437236,0.841386,1.55113,0.380786,0.825437,1.24901,2.40767,0.411696,0.608816,0.144706,0.563758,0.902078,0.536514,1.24975,0.582863,0.831295,0.261619,0.610669,0.474221,0.788421,1.05665,0.859154,0.663409,0.646474,1.12346,0.99279,0.371606,1.3966,1.41464,0.940919,0.657156,2.06538,0.425455,0.938668,1.22795,2.29231,0.494668,1.11142,0.953187,1.15459,1.55483,1.90983,1.22303,1.7608,0.700291,0.474956,0.284975,1.44925,0.416814,1.03818,0.411601,1.04436,1.20986,0.684144,0.476502,1.16055,1.00151,0.459035,1.32978,0.181575,0.195254,0.380977,1.06194,2.07346,1.62608,1.33496,1.26245,0.595071,0.531443,0.509215,0.464141,1.26539,1.05692,0.352122,0.563856,1.24872,1.37854,1.12409,1.12297,0.830796,1.18646,0.854628,0.689894,0.681267,0.744607,1.38039,0.685481,0.876299,1.63327,0.580657,3.34241,0.805461,1.14346,0.559153,1.45481,1.08896,0.965352,1.04338,1.68841,1.21376,0.928483,1.25534,1.55328,0.598722,1.36093,0.792832,1.52297,0.955954,1.65529,0.273451,0.762499,0.832891,1.60513,2.44352,2.04137,1.55966,0.978551,1.26,1.11604,0.831808,1.06002,2.40374,0.765221,0.589976,0.38417,0.721422,1.39822,0.516739,0.954936,1.48249,0.993889,0.622823,0.749933,0.762177,1.61484,1.32889,1.21423,0.741984,1.11251,0.94678,0.562367,0.904334,0.135528
}}
}}

Revision as of 22:35, 26 November 2012


Phase1 CAGE Peaks

 Short description
Mm9::chr1:122237182..122237222,+p1@C1ql2
Mm9::chr1:122237232..122237241,+p4@C1ql2
Mm9::chr1:122237337..122237346,+p6@C1ql2


Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data


no results for this coexpression

Relative expression of the co-expression cluster over median <br>Analyst:





Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br>cell_data<br>uberon_data<br><br>


Uber Anatomy
Ontology termp-valuen
ectoderm-derived structure2.47e-2495
ectoderm2.47e-2495
presumptive ectoderm2.47e-2495
nervous system1.18e-2275
central nervous system8.75e-2073
neurectoderm5.72e-1664
neural plate5.72e-1664
presumptive neural plate5.72e-1664
regional part of nervous system6.95e-1554
ecto-epithelium2.65e-1373
neural tube3.98e-1252
neural rod3.98e-1252
future spinal cord3.98e-1252
neural keel3.98e-1252
pre-chordal neural plate8.78e-1249
basal ganglion7.26e-118
nuclear complex of neuraxis7.26e-118
aggregate regional part of brain7.26e-118
collection of basal ganglia7.26e-118
cerebral subcortex7.26e-118
regional part of midbrain4.70e-104
midbrain4.70e-104
presumptive midbrain4.70e-104
midbrain neural tube4.70e-104
structure with developmental contribution from neural crest2.09e-0992
regional part of brain1.89e-0846
substantia nigra2.08e-083
telencephalic nucleus2.08e-083
midbrain nucleus2.08e-083
neural nucleus2.08e-083
nucleus of brain2.08e-083
brain3.36e-0847
future brain3.36e-0847
gray matter1.08e-0734
anterior neural tube2.04e-0740
regional part of spinal cord2.34e-075
gray matter of spinal cord2.34e-075
parasympathetic nervous system2.87e-073


TFBS overrepresentation<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data


Novel motifs




JASPAR motifs


Motifs-log10(p-value)

{{{tfbs_overrepresentation_jaspar}}}